Last update 05 Dec 2025

Hemay808

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HEMAY-808
Target
IgE x PDE4
Action
inhibitors
Mechanism
IgE inhibitors(Immunoglobulin E inhibitors), PDE4 inhibitors(Phosphodieterase 4 inhibitors)
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Mild Atopic DermatitisModerate Atopic Dermatitis
Originator Organization
Tianjin Hemay Pharmaceutical Technology Co., Ltd.Tianjin Hemay Pharmaceutical Technology Co., Ltd.
Active Organization-
Inactive Organization
Tianjin Hemay Pharmaceutical Technology Co., Ltd.Tianjin Hemay Pharmaceutical Technology Co., Ltd.Tianjin Hemei Biological Technology Co.,Ltd.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Hemay808
NCT04352595
/ CompletedPhase 2
Assess Hemay808 Concentration of Different Dosage Regimen for Mild and Moderate Atopic Dermatitis Patients the Safety and Efficacy of Multicenter, Randomized, Blinded, Excipient Parallel-group Phase Ⅱ Clinical Study
NCT04100642
/ CompletedPhase 1
A Phase I Clinical Study Assessed the Safety Tolerance and Pharmacokinetic Characteristics of Hemay808 in Healthy Adult Volunteers
100 Clinical Results associated with Hemay808
Login to view more data
100 Translational Medicine associated with Hemay808
Login to view more data
100 Patents (Medical) associated with Hemay808
Login to view more data
100 Deals associated with Hemay808
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mild Atopic DermatitisPhase 2
China
Tianjin Hemay Pharmaceutical Technology Co., Ltd.Tianjin Hemay Pharmaceutical Technology Co., Ltd.
28 Apr 2020
Moderate Atopic DermatitisPhase 2
China
Tianjin Hemay Pharmaceutical Technology Co., Ltd.Tianjin Hemay Pharmaceutical Technology Co., Ltd.
28 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free